Article in Genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors.
Andrea DuminucoHematology with BMT Unit, A.O.U. Policlinico "G. Rodolico-S. Marco", 95123 Catania, Italy.ORCID 0000-0002-9510-4755
Silvia Rita VitaleCenter of Experimental Oncology and Hematology, A.O.U. Policlinico "G. Rodolico-S. Marco", 95123 Catania, Italy.ORCID 0000-0002-7948-3580
Antonella NardoHematology with BMT Unit, A.O.U. Policlinico "G. Rodolico-S. Marco", 95123 Catania, Italy.
Patrick HarringtonDepartment of Haematology, Guy's and St Thomas' NHS Foundation Trust, London SE1 9RT, UK.ORCID 0000-0001-5704-466X
Stefania StellaCenter of Experimental Oncology and Hematology, A.O.U. Policlinico "G. Rodolico-S. Marco", 95123 Catania, Italy.
Michele MassiminoCenter of Experimental Oncology and Hematology, A.O.U. Policlinico "G. Rodolico-S. Marco", 95123 Catania, Italy.ORCID 0000-0001-5896-8573
Cristina TomarchioCenter of Experimental Oncology and Hematology, A.O.U. Policlinico "G. Rodolico-S. Marco", 95123 Catania, Italy.ORCID 0000-0002-1044-1008
Elisa MauroHematology with BMT Unit, A.O.U. Policlinico "G. Rodolico-S. Marco", 95123 Catania, Italy.
Marina S ParisiHematology with BMT Unit, A.O.U. Policlinico "G. Rodolico-S. Marco", 95123 Catania, Italy.
Cinzia MaugeriHematology with BMT Unit, A.O.U. Policlinico "G. Rodolico-S. Marco", 95123 Catania, Italy.
Francesco Di RaimondoHematology with BMT Unit, A.O.U. Policlinico "G. Rodolico-S. Marco", 95123 Catania, Italy.
Giuseppe A PalumboHematology with BMT Unit, A.O.U. Policlinico "G. Rodolico-S. Marco", 95123 Catania, Italy.ORCID 0000-0003-1859-6319
Livia ManzellaCenter of Experimental Oncology and Hematology, A.O.U. Policlinico "G. Rodolico-S. Marco", 95123 Catania, Italy.
Calogero VetroHematology and Bone Marrow Transplantation Unit, Hospital of Bolzano (SABES-Azienda Sanitaria dell' Alto Adige), Teaching Hospital of Paracelsus Medical University, 39100 Bolzano, Italy.ORCID 0000-0003-1922-5157
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
Leukemia, Myeloid, AcuteTumor Suppressor Protein p53AdultAgedAged, 80 and overFemaleGenomicsHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedMutationPrognosisRetrospective StudiesTP53 protein, humanTumor Suppressor Protein p53acute myeloid leukemianext-generation sequencingprognosisSangel AML modelTP53
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Integrating Genomic and Clinical Data in AML: Real-World Application of the Sanger Multistage Model. · full record | OpenQuestion